297 related articles for article (PubMed ID: 30155493)
21. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
22. CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity.
Filaci G; Fenoglio D; Indiveri F
Autoimmunity; 2011 Feb; 44(1):51-7. PubMed ID: 20670118
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
25. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
Avivi I; Stroopinsky D; Rowe JM; Katz T
Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
[TBL] [Abstract][Full Text] [Related]
26. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
28. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
Mutis T; Aarts-Riemens T; Verdonck LF
Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
[TBL] [Abstract][Full Text] [Related]
29. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
30. Maintenance of CD8+ T-cell anergy by CD4+CD25+ regulatory T cells in chronic graft-versus-host disease.
Kim J; Kim HJ; Choi WS; Nam SH; Cho HR; Kwon B
Exp Mol Med; 2006 Oct; 38(5):494-501. PubMed ID: 17079865
[TBL] [Abstract][Full Text] [Related]
31. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
[TBL] [Abstract][Full Text] [Related]
32. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
[TBL] [Abstract][Full Text] [Related]
33. [CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential].
Salomon B
J Soc Biol; 2002; 196(4):263-6. PubMed ID: 12645292
[TBL] [Abstract][Full Text] [Related]
34. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
35. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
36. Subpopulations of equine blood lymphocytes expressing regulatory T cell markers.
Robbin MG; Wagner B; Noronha LE; Antczak DF; de Mestre AM
Vet Immunol Immunopathol; 2011 Mar; 140(1-2):90-101. PubMed ID: 21208665
[TBL] [Abstract][Full Text] [Related]
37. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
[TBL] [Abstract][Full Text] [Related]
38. Induction of Immunosuppressive CD8
Lee J; Park N; Park JY; Kaplan BLF; Pruett SB; Park JW; Park YH; Seo KS
J Immunol; 2018 Jan; 200(2):669-680. PubMed ID: 29237775
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.
Hall BM
Transplantation; 2016 Dec; 100(12):2533-2547. PubMed ID: 27861285
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
